Search bioRxiv⌕ Search

Biology subjects

Majumdar, I.

Publications and source records attributed to Majumdar, I..

2 recordsLinked to original sources

TESOGENASE, An Engineered Nuclease Editor for Enhanced Targeted Genome Integration

Summary/AbstractNon-viral DNA donor template has been widely used for targeted genomic integration by homologous recombination (HR). This process has become more efficient with RNA guided endonuclease editor system such as CRISPR/Cas9. Circular single stranded DNA (cssDNA) has been harnessed previously as a genome engineering catalyst (GATALYST) for efficient and safe targeted gene knock-in. However, the engineering efficiency is bottlenecked by the nucleoplasm trafficking and genomic tethering of cssDNA donor, especially for extra-large transgene integration. Here we developed enGager, enhanced GATALYST associated genome editor system by fusion of nucleus localization signal (NLS) peptide tagged Cas9 with various single stranded DNA binding protein modules through a GFP reporter Knock-in screening. The enGager system assembles an integrative genome integration machinery by forming tripartite complex for engineered nuclease editors, sgRNA and ssDNA donors, thereby facilitate the nucleus trafficking of DNA donors and increase their active local concentration at the targeted genomic site. When applied for genome integration with cssDNA donor templates to diverse genomic loci in various cell types, these enGagers outperform unfused editors. The enhancement of integration efficiency ranges from 1.5- to more than 6-fold, with the effect being more prominent for > 4Kb transgene knock-in in primary cells. We further demonstrated that enGager mediated enhancement for genome integration is ssDNA, but less dsDNA dependent. Using one of the mini-enGagers, we demonstrated large chimeric antigen receptor (CAR) transgene integration in primary T cells with exceptional efficiency and anti-tumor function. These tripartite editors with ssDNA optimized genome engineering system (TESOGENASETM) add a set of novel endonuclease editors into the gene-editing toolbox for potential cell and gene therapeutic development based on ssDNA mediated non-viral genome engineering. HighlightO_LIA reporter Knock-in screening establishes enGager system to identify TESOGENASE editor to improving ssDNA mediated genome integration C_LIO_LIMini-TESOGENASEs developed by fusing Cas9 nuclease with novel ssDNA binding motifs C_LIO_LImRNA mini-TESOGENASEs enhance targeted genome integration via various non-viral delivery approaches C_LIO_LIEfficient functional CAR-T cell engineering by mini-TESOGENASE C_LI

bioengineering↗

Circular single-stranded DNA is a superior homology-directed repair donor template for efficient genome engineering

The toolbox for genome editing in basic research and therapeutic applications is rapidly expanding. While efficient targeted gene ablation using nuclease editors has been demonstrated from bench to bedside, precise transgene integration remains a technical challenge. AAV6 has been a prevalent donor carrier for homology-directed repair (HDR) mediated genome engineering but has reported safety issues, manufacturing constraints, and restricted applications due to its 4.5 Kb packaging limit. Non-viral targeted genetic knock-ins rely primarily on double-stranded DNA (dsDNA) and linear single-stranded DNA (lssDNA) donors. Both dsDNA and lssDNA have been previously demonstrated to have low efficiency and cytotoxicity. Here, we developed a non-viral genome writing catalyst (GATALYST) system which allows production of ultrapure, minicircle single-stranded DNAs (cssDNAs) up to [~]20 Kb as donor templates for highly efficient precision transgene integration. cssDNA donors enable knock-in efficiency of up to 70% in induced pluripotent stem cells (iPSCs), superior efficiency in multiple clinically relevant primary cell types, and at multiple genomic loci implicated for clinical applications with various nuclease editor systems. When applied to immune cell engineering, cssDNA engineered CAR-T cells exhibit more potent and durable anti-tumor efficacy than those engineered from AAV6 viral vectors. The exceptional precision and efficiency, improved safety, payload flexibility, and scalable manufacturability of cssDNA unlocks the full potential of genome engineering with broad applications in therapeutic development, disease modeling and other research areas. HighlightsO_LIScalable production of minicircle ssDNA (cssDNA) with highly engineered phagemid system C_LIO_LIGenome writing catalyst (GATALYST) system with cssDNA donor template demonstrates superior efficiency and safety in various cell types and genomic loci C_LIO_LIGATALYST gene writing system enables ultra-large transgene integration C_LIO_LIcssDNA engineered CAR-T outperforms AAV engineered CAR-T with superior anti-tumor function C_LI

bioengineering↗